
Buy Pancragen Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.

Buy Pancragen Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA on Request
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA on Request
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
What is Pancragen?
Pancragen is a synthetic four-amino-acid peptide bioregulator from the Russian program, designed to target the pancreas. It is studied in animal research for its effects on insulin-producing cells and blood-sugar control in the context of aging.
- A short peptide studied for its effects on pancreas tissue
- Studied in animal research for its effects on insulin-producing cell gene activity
- Investigated in aged primate models with impaired blood-sugar control
- Research focus includes age-related changes in blood-sugar handling
For research use only. Not approved for human therapeutic use.
Pancragen, also known by its tetrapeptide designation KEDW (Lys-Glu-Asp-Trp), is a synthetic tetrapeptide bioregulator with an approximate molecular weight of 576 g/mol. Developed at the Saint Petersburg Institute of Bioregulation and Gerontology as part of the Khavinson peptide bioregulator series, Pancragen was designed based on peptide fractions associated with pancreatic tissue. Its sequence, Lys-Glu-Asp-Trp, incorporates a C-terminal tryptophan residue, an aromatic amino acid containing the indole ring system. The KED core motif is shared with Vesugen, Testagen, and Prostamax, with the C-terminal residue varying across the organ-specific bioregulator series. Produced via solid-phase peptide synthesis, Pancragen is associated with pancreatic tissue gene expression and endocrine pancreatic signalling pathways.
Pancragen is an organ-specific tetrapeptide bioregulator within the Khavinson framework. A dedicated in vitro study has shown that in dissociated cultures of pancreatic cells from young and aged animals, pancragen stimulated the expression of differentiation factors of acinar cells and of the islets of Langerhans, the expression of which otherwise declined with culture ageing, consistent with a model in which the peptide acts on the transcriptional programme governing insulin-producing and acinar cell identity [1]. An in vivo study in aged female rhesus monkeys with impaired glucose tolerance reported that pancragen administration was associated with greater glucose clearance and normalisation of the insulin and C-peptide responses relative to the aged control pattern, with partial persistence after administration ceased [2], making Pancragen a reference compound in preclinical endocrinology research examining pancreatic-cell differentiation, age-associated glucose intolerance, and organ-specific short-peptide regulation of endocrine pancreatic function.
Pancragen is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available on request.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Scientific Review

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed for scientific accuracy, 14 June 2026
Lyophilised powder: store at -20 °C or below, away from light and moisture. Once reconstituted in an appropriate laboratory diluent (e.g. sterile water, PBS, or assay buffer), store at 2–8 °C and use within the validated period for your protocol. Do not refreeze.
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Related Compounds

N-Acetyl Epitalon
Mol. Wt.
432.38 g/mol
Purity
≥98%
CAS No.
N/A (modified Epitalon form)

Cartalax
Mol. Wt.
333.31 g/mol
Purity
≥98%
CAS No.
N/A (Khavinson bioregulator)

Prostamax
Mol. Wt.
487.51 g/mol
Purity
≥98%
CAS No.
N/A (Khavinson bioregulator)
Select Size
Get notified when this batch is released
Enter your email and we'll let you know as soon as this product is available again.
Quality Guaranteed
Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis and MSDS available on request.



